FDA Inspection
QuVa Pharma, Inc.QuVa Pharma, Inc. – FDA Inspection, May 4, 2026
Record Details
This FDA Inspection record concerns QuVa Pharma, Inc., with an inspection on May 4, 2026, issued by the Dallas District Office, covering human drugs.
View Company Profile
ID · ed8a4068-cb2f-474c-96db-d15e17113651
Inspection Facts
- Inspection number
- 1282296
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.58Buildings not maintained in good state of repair
Full citation text and observation details available on the Dashboard.
Other FDA inspections of QuVa Pharma, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| October 28, 2024 | VAI | Dallas District Office | Drug Quality Assurance |
| August 18, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 23, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 2, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 8, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for QuVa Pharma, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.